Preliminary molecular genetic analysis of the Receptor Interacting Protein 140 (RIP140) in women affected by endometriosis

  • Virginia Caballero
  • Rocío Ruiz
  • José Antonio Sainz
  • Marina Cruz
  • Miguel Angel López-Nevot
  • José Jorge Galán
  • Luis Miguel Real
  • Francisco de Castro
  • Vicente López-Villaverde
  • Agustín Ruiz
Open Access



Endometriosis is a complex disease affecting 10–15% of women at reproductive age. Very few genes are known to be altered in this pathology. RIP140 protein is an important cofactor of oestrogen receptor and many other nuclear receptors. Targeting disruption experiments of nrip1 gene in mice have demonstrated that nuclear receptor interacting protein 1 gene (nrip1), the gene encoding for rip140 protein, is essential for female fertility. Specifically, mice null for nrip1 gene are viable, but females are infertile because of complete failure of mature follicles to release oocytes at ovulation stage. The ovarian phenotype observed in mice devoid of rip140 closely resembles the luteinized unruptured follicle (LUF) syndrome that is observed in a high proportion of women affected of endometriosis or idiopathic infertility. Here we present a preliminary work that analyses the role of NRIP1 gene in humans.


We have sequenced the complete coding region of NRIP1 gene in 20 unrelated patients affected by endometriosis. We have performed genetic association studies by using the DNA variants identified during the sequencing process.


We identified six DNA variants within the coding sequence of NRIP1 gene, and five of them generated amino acid changes in the protein. We observed that three of twenty sequenced patients have specific combinations of amino-acid variants within the RIP140 protein that are poorly represented in the control population (p = 0.006). Moreover, we found that Arg448Gly, a common polymorphism located within NRIP1 gene, is associated with endometriosis in a case-control study (59 cases and 141 controls, pallele positivity test = 0.027).


Our results suggest that NRIP1 gene variants, separately or in combinations, might act as predisposing factors for human endometriosis.



We are deeply grateful to patients and controls for participation in this study. Funded by the Ministerio de Ciencia y Tecnología (MCYT, Spain, grant numbers FIT-010000-2003-36, FIT-010000-2003-89, FIT-010000-2003-70, PTQ2002-0206) and Organón Española S.A. (BCN, Spain).


  1. 1.
    Bulum SE, Zeitoun KM, Takayama K, Sasano H: Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. J Mol Endocrinol. 2000, 25: 35-42. 10.1677/jme.0.0250035.CrossRefGoogle Scholar
  2. 2.
    Donnez J, Thomas K: Incidence of luteinized unruptured follicle syndrome in fertile women and women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 1982, 14: 187-190. 10.1016/0028-2243(82)90095-8.CrossRefPubMedGoogle Scholar
  3. 3.
    White R, Leonardsson G, Rosewell I, Ann Jacobs M, Milligan S, Parker M: The nuclear receptor co-repressor Nrip1 (RIP140) is essential for female fertility. Nat Med. 2000, 6: 1368-1374. 10.1038/82183.CrossRefPubMedGoogle Scholar
  4. 4.
    García-Velasco JA, Arici A: Is the endometrium or oocyte/embryo affected in endometriosis?. Hum Reprod. 1999, 2: 77-89.CrossRefGoogle Scholar
  5. 5.
    Vercammen EE, D'Hooghe TM: Endometriosis and recurrent pregnancy loss. Semin Reprod Med. 2000, 18: 363-368. 10.1055/s-2000-13726.CrossRefPubMedGoogle Scholar
  6. 6.
    Leonardsson G, Steel JH, Christian M, Pocock V, Milligan S, Bell J, So PW, Medina-Gomez G, Vidal-Puig A, White R, Parker MG: Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci U S A. 2004, 101: 8437-42. 10.1073/pnas.0401013101.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    American Society for Reproductive Medicine: Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997, 67: 817-821. 10.1016/S0015-0282(97)81391-X.CrossRefGoogle Scholar
  8. 8.
    Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG: Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 1995, 14: 3741-3751.PubMedPubMedCentralGoogle Scholar
  9. 9.
    den Dunnen JT, Antonarakis SE: Nomenclature for the description of human sequence variations. Hum Genet. 2001, 109: 121-124. 10.1007/s004390100505.CrossRefPubMedGoogle Scholar
  10. 10.
    Gonzalez A, Abril E, Roca A, Aragon MJ, Figueroa MJ, Velarde P, Royo JL, Real LM, Ruiz A: CAPN10 alleles are associated with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002, 87: 3971-3976. 10.1210/jc.87.8.3971.CrossRefPubMedGoogle Scholar
  11. 11.
    Sasieni PD: From genotypes to genes: doubling the sample size. Biometrics. 1997, 53: 1253-1261.CrossRefGoogle Scholar
  12. 12.
    Georgiou I, Syrrou M, Bouba I, Dalkalitsis N, Paschopoulos M, Navrozoglou I, Lolis D: Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril. 1999, 72: 64-66. 10.1016/S0015-0282(99)00198-3.CrossRefGoogle Scholar
  13. 13.
    Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura N, Yoshikawa T, Honjo H: Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod. 2002, 17: 897-902. 10.1093/humrep/17.4.897.CrossRefPubMedGoogle Scholar
  14. 14.
    Wieser F, Schneeberger C, Tong D, Tempfer C, Huber JC, Wenzl R: PROGINS receptor gene polymorphism is associated with endometriosis. Fertil Steril. 2002, 77: 309-312. 10.1016/S0015-0282(01)02984-3.CrossRefPubMedGoogle Scholar
  15. 15.
    Dogan S, Machicao F, Wallwiener D, Haering HU, Diedrich K, Hornung D: Association of peroxisome proliferator-activated receptor gamma 2 Pro-12-Ala polymorphism with endometriosis. Fertil Steril. 2004, 81: 1411-1413. 10.1016/j.fertnstert.2003.10.026.CrossRefPubMedGoogle Scholar
  16. 16.
    Baranova H, Canis M, Ivaschenko T, Albuisson E, Bothorishvilli R, Baranov V, Malet P, Bruhat MA: Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Mol Hum Reprod. 1999, 5: 636-641. 10.1093/molehr/5.7.636.CrossRefPubMedGoogle Scholar
  17. 17.
    Arvanitis DA, Goumenou AG, Matalliotakis IM, Koumantakis EE, Spandidos DA: Low-penetrance genes are associated with increased susceptibility to endometriosis. Fertil Steril. 2001, 76: 1202-1206. 10.1016/S0015-0282(01)02865-5.CrossRefPubMedGoogle Scholar
  18. 18.
    Arvanitis DA, Koumantakis GE, Goumenou AG, Matalliotakis IM, Koumantakis EE, Spandidos DA: CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis. Fertil Steril. 2003, 702-709. 10.1016/S0015-0282(02)04817-3. Suppl 1CrossRefGoogle Scholar
  19. 19.
    Moutsatsou P, Sekeris CE: Steroid receptors in the uterus: implications in endometriosis. Ann N Y Acad Sci. 2003, 997: 209-222. 10.1196/annals.1290.024.CrossRefPubMedGoogle Scholar
  20. 20.
    Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H: Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol. 2002, 83: 149-155. 10.1016/S0960-0760(02)00260-1.CrossRefPubMedGoogle Scholar
  21. 21.
    Kastner P, Mark M, Leid M, Gansmuller A, Chin W, Grondona JM, Decimo D, Krezel W, Dierich A, Chambon P: Abnormal spermatogenesis in RXR beta mutant mice. Genes Dev. 1996, 10: 80-92.CrossRefGoogle Scholar
  22. 22.
    Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M: Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development. 2000, 127: 4277-4291.PubMedGoogle Scholar
  23. 23.
    Cui Y, Miyoshi K, Claudio E, Siebenlist UK, Gonzalez FJ, Flaws J, Wagner KU, Hennighausen L: Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chem. 2002, 17: 17830-17835. 10.1074/jbc.M200186200.CrossRefGoogle Scholar
  24. 24.
    Nakamura T, Yao R, Ogawa T, Suzuki T, Ito C, Tsunekawa N, Inoue K, Ajima R, Miyasaka T, Yoshida Y, Ogura A, Toshimori K, Noce T, Yamamoto T, Noda T: Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor beta. Nat Genet. 2004, 36: 528-533. 10.1038/ng1344.CrossRefPubMedGoogle Scholar
  25. 25.
    Hoh J, Ott J: Genetic dissection of diseases: design and methods. Curr Opin Genet Dev. 2004, 14: 229-232. 10.1016/j.gde.2004.04.006.CrossRefPubMedGoogle Scholar
  26. 26.
    Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M, Chambon P: Function of retinoic acid receptor gamma in the mouse. Cell. 1993, 21: 643-658. 10.1016/0092-8674(93)90246-M.CrossRefGoogle Scholar
  27. 27.
    Dufour JM, Vo MN, Bhattacharya N, Okita J, Okita R, Kim KH: Peroxisome proliferators disrupt retinoic acid receptor alpha signaling in the testis. Biol Reprod. 2003, 68: 1215-1224. 10.1095/biolreprod.102.010488.CrossRefPubMedGoogle Scholar
  28. 28.
    Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH: Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 2004, 305: 869-872. 10.1126/science.1099870.CrossRefPubMedGoogle Scholar
  29. 29.
    Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003, 33: 177-182. 10.1038/ng1071.CrossRefPubMedGoogle Scholar
  30. 30.
    Zilliacus J, Holter E, Wakui H, Tazawa H, Treuter E, Gustafsson JA: Regulation of glucocorticoid receptor activity by 14-3-3-dependent intracellular relocalization of the corepressor RIP140. Mol Endocrinol. 2001, 15: 501-511. 10.1210/me.15.4.501.CrossRefPubMedGoogle Scholar
  31. 31.
    Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P, Yanagisawa J, Fujii-Kuriyama Y, Kato S: Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature. 2003, 423: 545-550. 10.1038/nature01606.CrossRefPubMedGoogle Scholar
  32. 32.
    Kumar MB, Tarpey RW, Perdew GH: Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. J Biol Chem. 1999, 274: 22155-22164. 10.1074/jbc.274.32.22155.CrossRefPubMedGoogle Scholar
  33. 33.
    Peters GA, Khan SA: Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP-140. Mol Endocrinol. 1999, 13: 286-296. 10.1210/me.13.2.286.CrossRefPubMedGoogle Scholar
  34. 34.
    Galan JJ, Buch B, Cruz N, Segura A, Moron FJ, Bassas L, Martinez-Pineiro L, Real LM, Ruiz A: Multilocus analyses of estrogen-related genes reveal the involvement of ESR1 gene in male infertility and the polygenic nature of the pathology. Fertil Steril.Google Scholar

Copyright information

© Caballero et al; licensee BioMed Central Ltd. 2005

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Authors and Affiliations

  • Virginia Caballero
    • 2
  • Rocío Ruiz
    • 1
  • José Antonio Sainz
    • 2
  • Marina Cruz
    • 2
  • Miguel Angel López-Nevot
    • 3
  • José Jorge Galán
    • 1
  • Luis Miguel Real
    • 1
  • Francisco de Castro
    • 4
  • Vicente López-Villaverde
    • 2
  • Agustín Ruiz
    • 1
  1. 1.Department of Structural GenomicsneoCodexSevilleSpain
  2. 2.Unidad de Reproducción. Servicio de Obstetricia y GinecologíaHospital de ValmeSevilleSpain
  3. 3.Servicio de Análisis ClínicosHospital Universitario Virgen de las NievesGranadaSpain
  4. 4.Unidad de Reproducción Humana AsistidaHospital Universitario Príncipe de AsturiasMadridSpain

Personalised recommendations